GlassScriptPhysician profile
Merryann Werley
NPI 1255755518
$3,699.31
in general payments reported to CMS, 2019-2025
40 companies · $919 in 2025
The $919 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $778 · 2022: $614 · 2023: $738 · 2024: $651 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127 · Consulting Fee: $175 · Education: $5.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.53 |
| Consulting Fee | $175.00 |
| Education | $5.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.24 | 2021-2025 | |
| Amgen INC. | $332.20 | 2022-2025 | Prolia, Otezla, Repatha |
| Novo Nordisk INC | $307.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $284.57 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $273.47 | 2021-2025 | |
| Lilly USA, LLC | $239.10 | 2021-2024 | Zepbound |
| Biohaven Pharmaceuticals, INC. | $180.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.01 | 2021-2025 | |
| Axsome Therapeutics, INC. | $116.14 | 2023-2025 | Auvelity |
| Corium, LLC | $111.43 | 2022-2025 | Azstarys |
| Dexcom, INC. | $102.86 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $87.29 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Neos Therapeutics, LP | $86.15 | 2022-2024 | Adzenys Xr-Odt |
| Exact Sciences Corporation | $62.78 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $58.67 | 2023-2025 | Veozah |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merryann Werley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.